Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment

被引：0
|
作者：
Rumende, Cleopas Martin [1 ]
机构：
[1] Univ Indonesia, Cipto Mangunkusumo Hosp, Fac Med, Dept Internal Med, Jakarta, Indonesia
来源：
ACTA MEDICA INDONESIANA | 2021年 / 53卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：141 / 142
页数：2
相关论文
共 50 条
  • [41] Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients
    Tremblay, Douglas
    Seah, Carina
    Schneider, Thomas
    Bhalla, Sheena
    Feld, Jonathan
    Naymagon, Leonard
    Wang, Bo
    Patel, Vaibhav
    Jun, Tomi
    Jandl, Thomas
    Rahman, Farah
    Liu, Sean T. H.
    Aberg, Judith A.
    Bouvier, Nicole
    CANCER MEDICINE, 2020, 9 (22): : 8571 - 8578
  • [42] Inflammasome Caspase-1 Signaling Promotes Pulmonary Fibrosis in Severe COVID-19
    Peukert, K.
    Feuerborn, C.
    Schulz, S.
    Fox, M.
    Sauer, A.
    Putensen, C.
    Coburn, M.
    Wilhelm, C.
    Bode, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [43] Pulmonary Cryptococcosis and Pulmonary Fibrosis: A Complication of COVID-19 Pneumonia
    Isaac, Sangeetha
    Pasha, Mohammed Afraz
    Isaac, Shalom
    Kyei-Nimako, Evans
    Lal, Amos
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [44] Dysregulation of Pulmonary Responses in Severe COVID-19
    Wu, Dandan
    Yang, Xuexian O.
    VIRUSES-BASEL, 2021, 13 (06):
  • [45] Metformin use and risk for COVID-19 infection and severe COVID-19 outcomes
    Dublin, Sascha
    Kuntz, Jennifer
    Floyd, James
    Walker, Rod
    Fortmann, Stephen
    Bayliss, Elizabeth
    Shortreed, Susan
    Harrington, Laura
    Lee, Mi
    Albertson-Junkans, Ladia
    Powers, John
    Fuller, Sharon
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 506 - 506
  • [46] Diabetes severity and the risks of COVID-19 infection and severe COVID-19 outcomes
    Dublin, Sascha
    Floyd, James
    Walker, Rod
    Kuntz, Jennifer
    Shortreed, Susan
    Fortmann, Stephen
    Bayliss, Elizabeth
    Harrington, Laura
    Fuller, Sharon
    Albertson-Junkans, Ladia
    Powers, John
    Lee, Mi
    Temposky, Lisa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 40 - 40
  • [47] Severe AEs after COVID-19 vaccination following COVID-19 infection
    Reactions Weekly, 2022, 1934 (1) : 10 - 10
  • [48] Metabolomic Biomarkers of Pulmonary Fibrosis in COVID-19 Patients One Year After Hospital Discharge
    Botello-Marabotto, Marina
    Tarraso, Julia
    Mulet, Alba
    Presa-Fernandez, Lucia
    Fernandez-Fabrellas, Estrella
    Portal, Jose A. Rodriguez
    Ros, Jose A.
    Lozano-Vicente, Desire
    Bernardos, Andrea
    Martinez-Bisbal, M. Carmen
    Martinez-Manez, Ramon
    Signes-Costa, Jaime
    JOURNAL OF MEDICAL VIROLOGY, 2025, 97 (03)
  • [49] PULSE-DOSE STEROIDS FOR USE IN PULMONARY FIBROSIS RELATED TO COVID-19 INFECTION
    Brady, James
    Wang, Yvette
    CHEST, 2021, 160 (04) : 1676A - 1676A
  • [50] Risk factors for pulmonary fibrosis followed by severe pneumonia in patients with COVID-19 infection: A prospective multi-center study
    Kim, Junghyun
    Chae, Ganghee
    Yoon, Hee-Young
    Kim, Won-Young
    Chung, Chi-Ryang
    Cho, Young-Jae
    Lee, Jinwoo
    Jegal, Yangjin
    Joh, Joon-Sung
    Park, Tae Yun
    Hwang, Jung Hwa
    Nam, Bo Da
    Song, Jin Woo
    RESPIROLOGY, 2023, 28 : 181 - 182
12345